Prostatic adenocarcinoma, Gleason 4+4; IHC: PSA+, NKX3.1+, PAX8-, p63- (anterior urethral lesion) & Possible nephrogenic metaplasia (prostatic urethral lesion). This evidence concerns the gene PAX8 and prostate adenocarcinoma.